Hemodynamic Benefit of Rest and Exercise Optimization of Cardiac Resynchronization Therapy
Authors:
- Tony StantonTSTony Stanton
- Brian A. HaluskaBHBrian A. Haluska
- Rodel LeanoRLRodel Leano
- Thomas H. MarwickTMThomas H. Marwick
- the CORE InvestigatorsTIthe CORE Investigators
- 22 January 2014
- journal article
- research article
- Published by Wiley in Echocardiography
- Vol. 31 (8) , 980-988
Abstract
The optimal method of cardiac resynchronization therapy (CRT) optimization is as yet unknown. We sought to investigate the responses of optimization at rest and on exercise. This 2 stage study involved 59 patients (age 65 ± 10, 75% male), who had all recently undergone successful CRT implantation. In the first stage, the 6‐month response was compared between 30 individuals who underwent resting echocardiographic optimization of CRT [atrioventricular (AV delay) plus ventriculo‐ventricular delays (VV delay)], compared with the 29 who did not. In the second stage, a subset of 37 patients from the original cohort were randomized (double‐blind) to either resting echocardiographic optimization (n = 20) or exercise echocardiographic optimization (n = 17) and followed for a further 6 months. Clinical and echocardiographic data were collected at each stage. Patients undergoing rest optimization demonstrated improvement in almost all variables and significantly in B‐type natriuretic peptide (BNP) in contrast to those without optimization. In a linear regression model, the only significant predictor of BNP change was whether an individual underwent resting optimization or not (β = 0.38, P = 0.04). In those undergoing resting optimization, the degree of change in AV delay was correlated with improvement in left ventricle (LV) end‐diastolic volume (r2 = 0.33, P < 0.01). Optimization on exercise was associated with a significant decrease in 6‐minute walk test compared to those randomized to rest optimization possibly due to inducing nonoptimization at rest. In conclusion, echocardiographic optimization of CRT at rest is superior to no optimization or optimization on exercise. Patients with the greatest change in AV delay to reach optimal may undergo greater LV remodeling.Keywords
This publication has 30 references indexed in Scilit:
- Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?Heart Failure Reviews, 2011
- Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic studyEP Europace, 2011
- Iterative Cardiac Output Measurement for Optimizing Cardiac Resynchronization Therapy: A Randomized, Blinded, Crossover StudyPacing and Clinical Electrophysiology, 2010
- Interventricular Delay Optimization: A Comparison among Three Different Echocardiographic MethodsEchocardiography, 2010
- Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart FailureJACC, 2009
- Doppler Echocardiographic Methods for Optimization of the Atrioventricular Delay during Cardiac Resynchronization TherapyEchocardiography, 2008
- Cardiac resynchronization therapy during rest and exercise: comparison of two optimization methodsEP Europace, 2008
- Optimizing the Programation of Cardiac Resynchronization Therapy Devices in Patients With Heart Failure and Left Bundle Branch BlockThe American Journal of Cardiology, 2007
- Usefulness of Atrioventricular Delay Optimization Using Doppler Assessment of Mitral Inflow in Patients Undergoing Cardiac Resynchronization TherapyThe American Journal of Cardiology, 2006
- Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window.Circulation, 1984